pargyline has been researched along with Chronic Kidney Failure in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nestor, G | 1 |
| Beroniade, V | 1 |
| Tutunaru, M | 1 |
| Vidt, DG | 1 |
2 other studies available for pargyline and Chronic Kidney Failure
| Article | Year |
|---|---|
[Secondary effects of hypotensive drugs in arterial hypertension of renal origin].
Topics: Adult; Antihypertensive Agents; Female; Guanethidine; Humans; Hydralazine; Hypertension, Renal; Kidn | 1970 |
An approach to the medical treatment of hypertension in the aged.
Topics: Age Factors; Aged; Antihypertensive Agents; Cerebrovascular Disorders; Coronary Disease; Diuretics; | 1969 |